Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Telaglenastat联合Everolimus治疗晚期肾细胞癌:一项随机、双盲、安慰剂对照的II期ENTRATA试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0061
Lee, Chung-Han; Motzer, Robert; Emamekhoo, Hamid; Matrana, Marc; Percent, Ivor; Hsieh, James J; Hussain, Arif; Vaishampayan, Ulka; Liu, Sandy; McCune, Steven; Patel, Vijay; Shaheen, Montaser; Bendell, Johanna; Fan, Alice C; Gartrell, Benjamin A; Goodman, Oscar B; Nikolinakos, Petros G; Kalebasty, Arash Rezazadeh; Zakharia, Yousef; Zhang, Zhentao; Parmar, Hema; Akella, Lalith; Orford, Keith; Tannir, Nizar M